Pharma Journalist - Page 781 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

PharmaMar signs licensing agreement with Eczacıbasi Group for Aplidin

Ammonett Pharma Receives Notice of Allowance of U.S. Patent for “Detecting and treating GHD”

Akebia Therapeutics appoints Rita Jain as SVP and CMO

TrialScope Launches Second Global Clinical Trial Disclosure Maturity

miRagen Therapeutics’s MRG- 106 receives EU Orphan Medicinal Product Designation

Sun Pharma announces that US FDA Filing acceptance of BLA for Tildrakizumab

KBI Biopharma Invests $30M for Expansion projects of Durham and Boulder sites

Selexis SA and OSE Immunotherapeutics signs agreement for development of OSE’s interleukin receptor 7 antagonist

Pierre Fabre acquires Igenica Biotherapeutics Immuno-Oncology

LSNE Contract Manufacturing and Selecta Biosciences signs manufacturing supply agreement